Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | F9 | P00740 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25463964 | 0.94 | ALOX5 (0.38) | ALOX5CYP11B1F9ATML3MBTL1 | |
| SCHEMBL23258165 | 0.94 | ALOX5 (0.42) | ALOX5CYP11B1F9PRKDCATM | |
| SCHEMBL23258159 | 0.93 | ALOX5 (0.38) | ALOX5CYP11B1F9ATML3MBTL1 | |
| SCHEMBL23258164 | 0.93 | ALOX5 (0.40) | ALOX5CYP11B1F9ATML3MBTL1 | |
| SCHEMBL23258268 | 0.93 | ALOX5 (0.40) | ALOX5CYP11B1F9ATML3MBTL1 | |
| SCHEMBL23258185 | 0.93 | ALOX5 (0.40) | ALOX5CYP11B1F9ATML3MBTL1 | |
| SCHEMBL23258162 | 0.92 | ALOX5 (0.38) | ALOX5CYP11B1ATML3MBTL1 | |
| SCHEMBL23258067 | 0.92 | ALOX5 (0.40) | ALOX5F9PRKDCATML3MBTL1 | |
| SCHEMBL21096881 | 0.92 | ALOX5 (0.42) | ALOX5CYP11B1F9PRKDCATM | |
| SCHEMBL26339468 | 0.92 | ALOX5 (0.34) | ALOX5CYP11B1F9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210119135-A1 | LUMINESCENCE DEVICE AND AMINE COMPOUND FOR LUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210119135-A1 | LUMINESCENCE DEVICE AND AMINE COMPOUND FOR LUMINESCENCE DEVICE | SLC18A1, SLC29A1, SAT1 | ALOX5 1578/4885CYP11B1 1814/4885F9 3041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.